A case report of nivolumab-induced myasthenia gravis and myositis in a metastatic renal cell carcinoma patient

Motzer, 2015, Nivolumab versus everolimus in advanced renal-cell carcinoma, N Engl J Med, 373, 1803, 10.1056/NEJMoa1510665 Suzuki, 2017, Nivolumab-related myasthenia gravis with myositis and myocarditis in Japan, Neurology, 89, 1127, 10.1212/WNL.0000000000004359 Takamatsu, 2018, Immune checkpoint inhibitors in the onset of myasthenia gravis with hyperCKemia, Ann Clin Transl Neurol, 5, 1421, 10.1002/acn3.654 Carr, 2010, A systematic review of population based epidemiological studies in Myasthenia Gravi, BMC Neurol, 10, 46, 10.1186/1471-2377-10-46 Khan, 2015, PD-L1hi B cells are critical regulators of humoral immunity, Nat Commun, 6, 5997, 10.1038/ncomms6997